Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2003 1
2004 1
2006 3
2007 5
2008 8
2009 5
2010 4
2011 6
2012 10
2013 11
2014 13
2015 27
2016 32
2017 27
2018 23
2019 23
2020 34
2021 45
2022 30
2023 31
2024 37
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

354 results

Results by year

Filters applied: . Clear all
Page 1
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.
Irwin MS, Naranjo A, Zhang FF, Cohn SL, London WB, Gastier-Foster JM, Ramirez NC, Pfau R, Reshmi S, Wagner E, Nuchtern J, Asgharzadeh S, Shimada H, Maris JM, Bagatell R, Park JR, Hogarty MD. Irwin MS, et al. J Clin Oncol. 2021 Oct 10;39(29):3229-3241. doi: 10.1200/JCO.21.00278. Epub 2021 Jul 28. J Clin Oncol. 2021. PMID: 34319759 Free PMC article.
Antibody humanization methods - a review and update.
Safdari Y, Farajnia S, Asgharzadeh M, Khalili M. Safdari Y, et al. Biotechnol Genet Eng Rev. 2013;29:175-86. doi: 10.1080/02648725.2013.801235. Epub 2013 Aug 2. Biotechnol Genet Eng Rev. 2013. PMID: 24568279 Review.
Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group.
Mody R, Yu AL, Naranjo A, Zhang FF, London WB, Shulkin BL, Parisi MT, Servaes SE, Diccianni MB, Hank JA, Felder M, Birstler J, Sondel PM, Asgharzadeh S, Glade-Bender J, Katzenstein H, Maris JM, Park JR, Bagatell R. Mody R, et al. J Clin Oncol. 2020 Jul 1;38(19):2160-2169. doi: 10.1200/JCO.20.00203. Epub 2020 Apr 28. J Clin Oncol. 2020. PMID: 32343642 Free PMC article. Clinical Trial.
The genetic landscape of high-risk neuroblastoma.
Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, Carter SL, Cibulskis K, Hanna M, Kiezun A, Kim J, Lawrence MS, Lichenstein L, McKenna A, Pedamallu CS, Ramos AH, Shefler E, Sivachenko A, Sougnez C, Stewart C, Ally A, Birol I, Chiu R, Corbett RD, Hirst M, Jackman SD, Kamoh B, Khodabakshi AH, Krzywinski M, Lo A, Moore RA, Mungall KL, Qian J, Tam A, Thiessen N, Zhao Y, Cole KA, Diamond M, Diskin SJ, Mosse YP, Wood AC, Ji L, Sposto R, Badgett T, London WB, Moyer Y, Gastier-Foster JM, Smith MA, Guidry Auvil JM, Gerhard DS, Hogarty MD, Jones SJ, Lander ES, Gabriel SB, Getz G, Seeger RC, Khan J, Marra MA, Meyerson M, Maris JM. Pugh TJ, et al. Nat Genet. 2013 Mar;45(3):279-84. doi: 10.1038/ng.2529. Epub 2013 Jan 20. Nat Genet. 2013. PMID: 23334666 Free PMC article.
Proteases of Acanthamoeba.
Mahdavi Poor B, Rashedi J, Asgharzadeh V, Mirmazhary A, Gheitarani N. Mahdavi Poor B, et al. Parasitol Res. 2023 Dec 8;123(1):19. doi: 10.1007/s00436-023-08059-z. Parasitol Res. 2023. PMID: 38063887 Review.
Diabetes and COVID-19; a Review of Possible Mechanisms.
Moradi-Marjaneh R, Asgharzadeh F, Khordad E, Marjaneh MM. Moradi-Marjaneh R, et al. Curr Pharm Des. 2021;27(21):2522-2527. doi: 10.2174/1381612827666210303141846. Curr Pharm Des. 2021. PMID: 33655850 Review.
Linezolid: a promising option in the treatment of Gram-positives.
Zahedi Bialvaei A, Rahbar M, Yousefi M, Asgharzadeh M, Samadi Kafil H. Zahedi Bialvaei A, et al. J Antimicrob Chemother. 2017 Feb;72(2):354-364. doi: 10.1093/jac/dkw450. Epub 2016 Dec 20. J Antimicrob Chemother. 2017. PMID: 27999068 Review.
354 results